Segantii Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Segantii Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-165,000	Closed	-$10.2M	–	347
2020 Q4	$10.2M	Buy	+165,000	New	+$10.1M	0.47%	47
2017 Q2	–	Sell	-10,000	Closed	-$544K	–	86
2017 Q1	$544K	Buy	+10,000	New	+$548K	0.09%	79
2016 Q4	–	Sell	-90,000	Closed	-$4.85M	–	136
2016 Q3	$4.85M	Buy	+90,000	New	+$5.78M	1.32%	23

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Segantii Capital Management's BMY Position: Q1 2021 in Review

Segantii Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 165,000 shares — an estimated $10.2M sold.

Segantii Capital Management first reported a position in BMY in Q3 2016 and held it in 3 quarters. The position peaked at $10.2M in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Segantii Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Segantii Capital Management sold 165,000 Bristol-Myers Squibb shares in Q1 2021, an estimated $10.2M.
Segantii Capital Management first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 3 quarters.
Segantii Capital Management's Bristol-Myers Squibb position peaked at $10.2M in Q4 2020.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Segantii Capital Management's 13F filing for Q1 2021, filed 11 May 2021.